Collagen proportionate area is an independent predictor of long‐term outcome in patients with non‐alcoholic fatty liver disease

Collagen proportionate area (CPA) measurement is a technique that quantifies fibrous tissue in liver biopsies by measuring the amount of collagen deposition as a proportion of the total biopsy area. CPA predicts clinical outcomes in patients with HCV and can sub‐classify cirrhosis.

[1]  R. Andrade,et al.  The effects of metabolic status on non‐alcoholic fatty liver disease‐related outcomes, beyond the presence of obesity , 2018, Alimentary pharmacology & therapeutics.

[2]  D. Schuppan,et al.  Predictors of advanced fibrosis in non‐cirrhotic non‐alcoholic fatty liver disease in Germany , 2018, Alimentary pharmacology & therapeutics.

[3]  E. Tsochatzis,et al.  Non-alcoholic fatty liver disease and the interface between primary and secondary care. , 2018, The lancet. Gastroenterology & hepatology.

[4]  M. Thiele,et al.  Collagen proportionate área is an independent predictor of long term outcome in patients with alcoholic liver disease , 2018 .

[5]  Y. Imai,et al.  Quantitative assessment of liver fibrosis reveals a nonlinear association with fibrosis stage in nonalcoholic fatty liver disease , 2017, Hepatology communications.

[6]  R. Wong,et al.  Significant burden of nonalcoholic fatty liver disease with advanced fibrosis in the US: a cross‐sectional analysis of 2011‐2014 National Health and Nutrition Examination Survey , 2017, Alimentary pharmacology & therapeutics.

[7]  Roberta Forlano,et al.  Assessment of non invasive markers of fibrosis against collagen quantitation and NASH-CRN scoring in liver biopsies of NAFLD patients , 2017 .

[8]  E. Tsochatzis,et al.  Surrogate endpoints for clinical trials in non-alcoholic steatohepatitis. , 2017, The Lancet Gastroenterology and Hepatology.

[9]  E. Tsochatzis,et al.  The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). , 2016, Metabolism: clinical and experimental.

[10]  V. Miller,et al.  Regulatory Science and Drug Approval for Alcoholic and Nonalcoholic Steatohepatitis. , 2016, Gastroenterology.

[11]  H. Tilg,et al.  EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. , 2016, Journal of hepatology.

[12]  E. Bjornsson,et al.  Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease. , 2015, Gastroenterology.

[13]  P. O’Rourke,et al.  ELF score ≥9.8 indicates advanced hepatic fibrosis and is influenced by age, steatosis and histological activity , 2015, Liver international : official journal of the International Association for the Study of the Liver.

[14]  Mats Fredrikson,et al.  Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up , 2015, Hepatology.

[15]  E. Tsochatzis,et al.  Noninvasive Assessment of Fibrosis in Patients with Nonalcoholic Fatty Liver Disease , 2015, International journal of endocrinology.

[16]  M. Bulsara,et al.  Image analysis of liver biopsy samples measures fibrosis and predicts clinical outcome. , 2014, Journal of hepatology.

[17]  A. Burroughs,et al.  Collagen proportionate area is superior to other histological methods for sub-classifying cirrhosis and determining prognosis. , 2014, Journal of hepatology.

[18]  A. Alibrandi,et al.  The relationship between transient elastography and histological collagen proportionate area for assessing fibrosis in chronic viral hepatitis , 2013, Journal of Gastroenterology.

[19]  R. Jalan,et al.  Beyond scoring: a modern interpretation of disease progression in chronic liver disease , 2013, Gut.

[20]  A. Burroughs,et al.  Digital image analysis of collagen assessment of progression of fibrosis in recurrent HCV after liver transplantation. , 2013, Journal of hepatology.

[21]  Andrew R. Hall,et al.  Sample size requirement for digital image analysis of collagen proportionate area in cirrhotic livers , 2013, Histopathology.

[22]  Giacomo Germani,et al.  Liver collagen proportionate area predicts decompensation in patients with recurrent hepatitis C virus cirrhosis after liver transplantation , 2012, Journal of gastroenterology and hepatology.

[23]  A. Zaman.  Practice Guidelines for Management of Nonalcoholic Fatty Liver Disease , 2012 .

[24]  Andrew R. Hall,et al.  Fibrosis distribution in explanted cirrhotic livers , 2012, Histopathology.

[25]  Ying Zhang,et al.  Collagen proportionate area of liver tissue determined by digital image analysis in patients with HBV-related decompensated cirrhosis. , 2011, Hepatobiliary & pancreatic diseases international : HBPD INT.

[26]  A. Burroughs,et al.  Noninvasive assessment of liver fibrosis: The need for better validation , 2011, Hepatology.

[27]  Amar P. Dhillon,et al.  Digital image analysis of liver collagen predicts clinical outcome of recurrent hepatitis C Virus 1 year after liver transplantation , 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[28]  Giacomo Germani,et al.  The relationship between liver disease stage and liver fibrosis: a tangled web , 2010, Histopathology.

[29]  E. Brunt.  Histopathology of non-alcoholic fatty liver disease. , 2009, Clinics in liver disease.

[30]  R. Standish,et al.  Computer‐assisted image analysis of liver collagen: Relationship to Ishak scoring and hepatic venous pressure gradient , 2009, Hepatology.

[31]  R. Koretz,et al.  Hepatology may have problems with putative surrogate outcome measures. , 2007, Journal of hepatology.

[32]  O. Cummings,et al.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.

[33]  Claude Lenfant,et al.  Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition , 2004, Circulation.

[34]  Claude Lenfant,et al.  Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[35]  Byrne,et al.  practice guidelines for the management of nonalcoholic fatty liver disease , 2016 .

[36]  A. Burroughs,et al.  Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation. , 2015, Health technology assessment.